Silver Book Fact

Anti-VEGF Visual Improvement

Fact image

Nearly 50% of DME patients who received an anti-VEGF drug, experienced substantial visual improvement after a year of injections.

Bressler N, Chang T, Fine J, et al. Vision-Related Function after Ranibizumab Treatment by Better- or Worse-Seeing Eye: Clinical trial results from MARINA and ANCHOR. Ophthalmol. 2010; 117(4): 747-56. http://www.aaojournal.org/article/S0161-6420(09)00981-6/abstract

Reference

Title
Vision-Related Function after Ranibizumab Treatment by Better- or Worse-Seeing Eye: Clinical trial results from MARINA and ANCHOR
Publication
Ophthalmol
Publication Date
2010
Authors
Bressler N, Chang T, Fine J, et al
Volume & Issue
Volume 117, Issue 4
Pages
747-56
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Every additional dollar spent on screening and treating diabetic eye disease in type 2 diabetics on insulin has produced health gains valued at $36.  
  • Blood pressure control reduces the risk of heart disease or stroke among Americans with diabetes by 33-50%.  
  • During the first year of a community pharmacy services program in 2003 which included 256 diabetes patients who used scheduled consultations, clinical goal setting, monitoring, and collaborative drug therapy management…  
  • 150 drugs are in development for diabetes. Diabetes affects 12.2 million Americans age 60 and older.  
  • Blood pressure control in diabetics reduces the risk of cardiovascular disease by 33% to 50%, and the risk of microvascular complications by approximately 33%.